Nature Index |

Infectious disease

COVID-19 has brought new urgency to the study of infectious disease. This Nature Index supplement shines a light on some of the research, and the people and institutions behind it, that aims to reduce the staggering human and economic cost of communicable disease

Features and comment

A description of the terminology and methodology used in this supplement, and a guide to the functionality that is available free online at

Nature Index | | Nature

Partner content

A*STAR Infectious Diseases Labs, in Singapore, addresses a range of diseases, from COVID-19 and its mutations to many other pathogens. Its mission includes defence against the next pandemic outbreak.

Advertisement Feature |

A newly integrated division of medicine and photonics at Tokushima University is investigating ways to inactivate the SARS-CoV-2 virus responsible for COVID-19.

Advertisement Feature |

The ability to break microorganisms, viruses, and endotoxins down into smaller fragments enhances the utility of sterilization systems in hospitals and laboratories.

Advertisement Feature |

By combining high-resolution techniques with virology and stem cell science, the Kyoto University Institute for Life and Medical Sciences is paving the way to a new frontier in virus research.

Advertisement Feature |